This track explores the convergence of medicines, diagnostics, and medical device technologies to deliver more precise, personalized treatment options and improve patient outcomes. It highlights advances in combination products, biomarkers, companion diagnostics, translational medicine, and next-generation drug delivery systems that are reshaping the therapeutic landscape. Sessions will showcase innovative strategies in compound selection, preclinical and clinical development, optimized dosing, and approaches to strengthen trial data quality and integrity for informed decision-making. Regulatory considerations, global trends, and emerging technologies will be examined, with emphasis on cross-sector collaborations and the integration of the patient’s voice early in development to ensure meaningful outcomes across diverse populations and therapeutic areas, including rare diseases and women’s health.

Browse Related eLearning Courses

Registration Rates

Back to DIA 2026

Back to DIAglobal.org